Neueste

  • Neue Fortschritte bei der Untersuchung des Mechanismus von Lianhua Qingwen-Kapseln zur Behandlung von COVID-19

    ​Kürzlich haben Prof. Caisheng Wu und Prof. Yifeng Chai von der School of Pharmacy, Xiamen University neue Fortschritte bei der Untersuchung der pharmakologisch aktiven Inhaltsstoffe und des Mechanismus von Lianhua Qingwen Kapseln bei der Prävention und Behandlung von COVID-19 gemacht. Das Ergebnis der Studie, "Screening of the Anti-COVID-19 Pharmacological Active Ingredients of Traditional Chines
  • Yutong совместно с компанией Mowasalat обслуживает Клубный чемпионат мира по футболу 2020 в Катаре

    4 февраля 2021 года в Катаре официально начался 17-й Клубный чемпионат мира по футболу ФИФА, в рамках которого в городе Доха собрались ведущие футбольные клубы из 5 континентов. Среди них такие звездные команды, как победитель Лиги чемпионов УЕФА — германский футбольный клуб «Бавария» и местный клуб Аль-Духайль. В чемпионате также приняли участие такие команды, как Палмейрас из Бразилии, Ульсан Хё
  • Equipped with UNISOC T618, ZTE Axon 20 4G with Under-Screen Camera Has Been Launched Overseas

    Shanghai, China, December X, 2020 - The 4G version of the flagship ZTE cellphone, the Axon 20 4G, with an under-screen camera, powered by a UNISOC T618 chipset, which is an 8-core CPU, is announced to be launched on the overseas markets such as Germany and Mexico.
  • The world’s first 4G camera-under-screen cellphone represents the coming era of the real full-screen cellphone

    The under-screen camera and the extremely narrow border can provide its users with bigger game graphics, and the length-to-width ratio is close to that of the movie screen-all bringing shocking visual effects.
  • BYD Wins the Largest Pure-Electric Bus Order outside of China

    Bogotá, Colombia - BYD is proud to announce that it has exclusively won cumulative orders to supply 1,002-unit pure-electric buses to the capital of Colombia, Bogotá. This tender was open to all bus technologies, yet BYD won the trust and cooperation of its partners in the fiercely competitive bidding process thanks to its cutting-edge technologies, products and services. This is the largest order
  • Dab the 5G Era with the Perfume of Books and Fragrance of Ink — allow full rein to a better life with Hisense A7

    On Dec 22nd, Hisense’s new reading flagship cellphone A7 series was officially launched. This series is the continuation of the characteristics of Hisense A series' most typical ink screen design, namely e-ink screen, a kind of screen that uses electronic ink, which is also known as e-paper displays. This is the world's first 5G cellphone equipped with an ink screen, marking the official arrival o
  • BYD Delivers Largest Pure Electric Bus Fleet in Colombia

    Bogota, Colombia - On December 17, BYD announced the delivery of 470 pure electric buses to Bogota, the capital of Colombia. This is the country’s largest pure electric bus fleet, and also the largest bus fleet BYD has delivered in the Americas, which will effectively promote the already fast-growing electrified public transport systems in Colombia, Latin America and the entire Americas.
  • UNISOC and CTTL Helped Fibocom to Obtain the World's First Cat.1bis Module GCF Certification

    On December 21, 2020, UNISOC, China Telecommunication Technology Labs (CTTL) and Fibocom jointly announced that Fibocom L610-EU module was officially awarded the world's first 3GPP UE category 1bis module (Cat.1bis for short) GCF/CE/NCC certification, which marked that the Fibocom Cat.1bis module equipped with the UNISOC 8910DM chip has the overseas supply capacity officially.
  • New Sapphire Timepiece by AET REMOULD - Sapphire Daytona

    On Christmas Eve, AET REMOULD specially launched the sapphire Daytona Xmas, which uses AET REMOULD's iconic sapphire crystal material and creates a brand new sapphire crystal Daytona.
  • Industry's First 5G Terminal Slicing Solution Demonstrated

    SHANGHAI, Dec 4, 2020 - UNISOC, with China Mobile, ZTE and other industry chain partners, jointly completed an application demonstration of the world's first 5G terminal slicing target solution, which indicates that 5G terminal has been equipped with the slicing capability and can provide personalized and customized services for 5G users. The demonstration took place at the 8th China Mobile Globa

Link

Yiling Pharmaceutical Lianhua Qingwen Capsule helps prevent and control the global epidemic

04-10    

On April 4, 2020, Phoenix TV broadcast a report on Yiling Pharmaceutical. It was reported that the global epidemic continued to worsen. At the China-Europe anti-epidemic exchange meeting, the recovery rate of patients treated with Lianhua Qingwen Capsule of Yiling Pharmaceutical co., LTD was as high as 91.5 percent, which has become a hot spot. Since 2004, Lianhua Qingwen Capsule has been listed by the national health commission of China, the state administration of traditional Chinese medicine and other departments in the treatment of influenza and other respiratory diseases for more than 20 times. It has played an important role in the prevention and control of major epidemics. On March 30, Lianhua Qingwen Capsule was approved by the ministry of health of Thailand for the registration of modern herbal medicine, which indicated that Yiling pharmaceutical co., a representative of modern Chinese medicine enterprises in China, had the qualification to sell Lianhua Qingwen Capsule as a drug in the Thai market.

Lianhua Qingwen Capsule helps prevent and control the global epidemic


At the beginning of 2020, COVID - 19 outbreak occurred in Wuhan, China, as the medicine recommended by the national health commission of China in the "diagnosis and treatment scheme of pneumonia infected by novel coronavirus", the market demand of Lianhua Qingwen capsules (granules) produced by Yiling Pharmaceutical co., LTD surged. In order to ensure market supply and help prevent and control the epidemic, all the production lines of Yiling Pharmaceutical co., ltd. are racing against time to produce Lianhua Qingwen products within 24 hours." When the outbreak came, we immediately donated 10 million yuan of Lianhua Qingwen capsules to the Red Cross society of China, of which 5 million yuan of Lianhua Qingwen capsules were transported overnight to the epidemic area in Wuhan to ensure the market demand. At the same time, we also donated products to foreign countries, such as Iraq and Italy. Yiling Pharmaceutical general manager Wu Xiangjun said in an interview.

In the covid-19 prevention and control programs successively released by more than 20 provinces and cities including Hubei, Guangzhou, Zhejiang, Shandong and Hebei, Lianyanghua Qingwen capsules (granules) are recommended. In an interview, Jia zhenhua, director of the Yiling medical research institute, pointed out that "the formula of Lianhua Qingwen is to include the pathogenesis of such diseases as exogenous febrile diseases (respiratory diseases caused by viruses in western medicine) and its treatment drugs."


The good curative effect of Lianhua Qingwen capsule is due to its characteristic of active intervention in multi-target therapy. Hou Yunlong, deputy director of the new drug evaluation center of Yiling medical research institute, told the reporter: "We found that Lianhua Qingwen has certain antiviral replication ability at the cell. When the virus infects the host cell, the host cell will have a certain immune response, and this immune response will release a number of pro-inflammatory factors.”

The overseas business layout of Yiling keeps accelerating

While actively promoting the fight against the "epidemic", Yiling Pharmaceutical's overseas business layout is also accelerating. On March 30, Yiling pharmaceutical announced that it had obtained the approval from the ministry of health of Thailand for the registration of modern herbal medicine, and approved Lianhua Qingwen capsules to comply with the registration of Thailand's modern herbal medicine standards, which brought more international recognition to traditional Chinese medicine.

"Through this outbreak, there has been a significant change in western European and American countries' understanding of traditional Chinese medicine." Zhao Shaohua, deputy general manager of Yiling Pharmaceutical co., said in an interview, "Lianhua Qingwen has been sold in some countries for many years. It used to be mainly used to treat flu, and there was a normal sale every year. Following the global outbreak of covid-19 this year, the demand for Lianhua Qingwen has increased exponentially. This has laid a very good foundation for Lianhua Qingwen 's future sales in the international market.

At present, Yiling Pharmaceutical products such as Tongxinluo capsule, Lianhua Qingwen capsule, Shensong Yangxin capsule, Qiliqiangxin capsule, Yangzheng Xiaoji capsule have been registered and sold in Korea, Vietnam, Russia, Canada, Singapore, Indonesia and other countries. Tongxinluo capsule has also been included in Vietnam's national health insurance directory. Lianhua Qingwen capsule has been registered in Hong Kong and Macao, as well as in Canada, Mozambique, Indonesia, Brazil, Romania, Thailand and other countries, and has carried out phase II clinical study in the United States.

On the internationalization of traditional Chinese medicine, Wu Xiangjun told reporters: "Yiling Pharmaceutical has set up the world federation of traditional Chinese medicine collateral disease branch, as well as in Canada, Europe, northern Europe. The theory of collateral disease has become a window for the world to understand the culture of traditional Chinese medicine, and a bright spot for the culture of traditional Chinese medicine to enter the world. With the deepening of people's understanding of traditional Chinese medicine and its wide spread, I believe traditional Chinese medicine will be a bright name card for China's internationalization in the future."



Haftungsausschluss: Dieser Artikel wurde aus anderen Medien reproduziert. Der Zweck des Nachdrucks besteht darin, mehr Informationen zu vermitteln. Dies bedeutet nicht, dass diese Website ihren Ansichten zustimmt und für ihre Authentizität verantwortlich ist und keine rechtliche Verantwortung trägt. Alle Ressourcen auf dieser Website werden im Internet gesammelt. Der Zweck des Teilens dient nur dem Lernen und Nachschlagen aller. Wenn eine Verletzung des Urheberrechts oder des geistigen Eigentums vorliegt, hinterlassen Sie uns bitte eine Nachricht.
Zurück nach oben
© Urheberrechte 2009-2020 TOM Nachrichtenportal      Kontaktieren Sie Uns   SiteMap